Drug Profile
Research programme: inflammatory bowel disease therapeutics - Calypso Biotech
Alternative Names: CALY-001; Gastrointestinal disorder antibody therapeutics - Calypso Biotech; Gastrointestinal immunological disease therapeutics - Calypso BiotechLatest Information Update: 15 Jan 2024
Price :
$50
*
At a glance
- Originator Calypso Biotech
- Class Antibodies; Monoclonal antibodies
- Mechanism of Action Matrix metalloproteinase 9 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Crohn's disease; Inflammatory bowel diseases